Early NT-proBNP Is Able to Predict Spontaneous Closure of Patent Ductus Arteriosus in Preterm Neonates, But Not the Need of Its Treatment

Attridge JT, Kaufman DA, Lim DS (2009) B-Type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 94:F178–F182

Benitz WE (2010) Treatment of persistent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 30:241–252

Chiruvolu A, Jaleel MA (2009) Therapeutic management of patent ductus arteriosus. Early Hum Dev 85(3):151–155

Clyman RI (2000) Ibuprofen and patent ductus arteriosus. N Engl J Med 343(10):728–730

El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L (2005) Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 90:F419–F422

El-Khuffash A, Davis PG, Walsh K, Molloy EJ (2008) Cardiac troponin T and N-terminal-pro-B natriuretic peptide reflect myocardial function in preterm infants. J Perinatol 28(7):482–486

Farombi-Oghuvbu I, Matthews T, Mayne PD, Guerin H, Corcoran JD (2008) N-Terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 93:F257–F260

Fowlie PW, Davis PG, McGuire W (2010) Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 7:CD000174

Hamrick SEG, Hansmann G (2010) Patent ductus arteriosus of the preterm infant. Pediatrics 125(5):1019–1030

Herrman K, Bose C, Lewis K, Laughon M (2009) Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed 94(1):F48–F50

Keane JF, Fyler DC (2006) Patent ductus arteriosus. In: Keane JF, Lock JE, Fyler DC (eds) Nadas’ pediatric cardiology, 2nd edn. Saunders/Elsevier, Philadelphia, pp 617–625

Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR (2006) Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117(4):1113–1121

Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, Pignatelli RH, Rychik J, Task Force of the Pediatric Council of the American Society of Echocardiography; Pediatric Council of the American Society of Echocardiography (2006) Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 19:1413–1430

McNamara PJ, Sehgal A (2007) Towards rational management of patent ductus arteriosus: the need for disease staging. Arch Child Fetal Neonatal Ed 92:F424–F427

Mercanti I, Boubred F, Simeoni U (2009) Therapeutic closure of the ductus arteriosus: benefits and limitations. J Matern Fetal Neonatal 22(Suppl 3):14–20

Nuntnarumit P, Khositseth A, Thanomsingh P (2009) N-Terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants. J Perinatol 29:137–142

Ramakrishnan S, Heung YM, Round J, Morris TP, Collinson P, Williams AF (2009) Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants. Acta Paediatr 98:1254–1259

Sehgal A, McNamara PJ (2009) Does echocardiography facilitate determination if hemodynamic significance attributable to ductus arteriosus? Eur J Pediatr 168:907–914

Skelton R, Evans N, Smythe J (1994) A blinded comparison of clinical and echocardiographical evaluation of the preterm infant for patent ductus arteriosus. J Paediatr Child Health 30:406–411